4 recruiting, 2 completed, 2 terminated. 4 Phase 2, 3 Phase 1, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Recruiting 3, Completed 1 |
| Phase 1 | 3 | Terminated 2, Recruiting 1 |
| Not applicable | 2 | Completed 1, Recruiting 1 |
Follow Biopsy of Breast: new trials by email Literature Review of Biopsy of Breast trials Research Report on Biopsy of Breast
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| [18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer Best Practice, Biopsy of Breast, Computed Tomography - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma | Phase 1 / Phase 2 | Recruiting | University of Washington | 22 | 2026-02-26 | 2026-05-19 |
| Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer Biopsy of Breast, Biospecimen Collection, Breast Surgery - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 2 | Recruiting | Mayo Clinic | 120 | 2025-05-14 | 2026-09-03 |
| Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers Endocrine Therapy, Biopsy of breast, Neratinib - Anatomic Stage I Breast Cancer, Anatomic Stage II Breast Cancer | Phase 2 | Recruiting | Vanderbilt-Ingram Cancer Center | 30 | 2024-06-11 | 2026-08-19 |
| Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities Biopsy of Breast, Medical Device Usage and Evaluation, Scintimammography - Breast Neoplasm | Not applicable | Recruiting | Mayo Clinic | 70 | 2021-08-26 | 2026-10-05 |
| Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer Biopsy of Breast, Copanlisib, Laboratory Biomarker Analysis - Estrogen Receptor Positive, HER2/Neu Negative | Phase 1 | Terminated | Jonsson Comprehensive Cancer Center | 10 | 2017-08-02 | 2022-09-26 |
| Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery Biopsy of Breast - Invasive Breast Carcinoma, Stage II Breast Cancer | Phase 2 | Completed | NRG Oncology | 105 | 2017-04-13 | 2025-05-22 |
| Ultrasound Imaging Technique in Detecting Breast Microcalcifications in Patients Undergoing Biopsy for a Breast Abnormality Ultrasound, MicoPure ultrasound, Biopsy of Breast - Breast Carcinoma, Microcalcification | Not applicable | Completed | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 85 | 2012-03-01 | 2025-05-15 |
| RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III Breast Cancer letrozole, gamma-secretase/Notch signalling pathway inhibitor RO4929097, therapeutic conventional surgery - Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer | Phase 1 | Terminated | National Cancer Institute (NCI) | 28 | 2010-11-01 | 2013-09-30 |
Breast Neoplasms (7) · Calcinosis (1) · Carcinoma, Lobular (1) · Triple Negative Breast Neoplasms (1)
Mayo Clinic (2) · Jonsson Comprehensive Cancer Center (1) · NRG Oncology (1) · National Cancer Institute (NCI) (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1) · University of Washington (1) · Vanderbilt-Ingram Cancer Center (1)
United States (7) · Canada (1)
Carlos E. Vargas, MD (1) · Flemming Forsberg, PhD (1) · Jennifer Specht, MD (1) · Katie N. Hunt, M.D. (1) · Laura Kennedy, MD, PhD (1) · Mark Basik (1) · Sara Hurvitz (1) · Shannon Puhalla (1)
PMID 33740205, PMID 38847615, PMID 40332918
R01CA273246 (1), U01CA099168 (1), U10CA180868 (1)